Porcine Virus In Merck's RotaTeq Raises Questions Of Timing, Testing

Revealed on the eve of an advisory committee meeting about safety of GSK's rival vaccine Rotarix, finding suggests that FDA and industry have considerable work to do on viral testing techniques.